Comments

DBV Technologies Stock Price, Quotes and Forecasts

Q: What sector and industry does DBV Technologies (DBVT) operate in?

DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

DBVTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

DBV Technologies (DBVT) Forecast

News Earnings DBV Technologies (DBVT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

DBV Technologies Stock Price, Quotes and Forecasts | NASDAQ:DBVT | Benzinga

Explore DBV Technologies stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DBVT.

Open	$9.35
Close	-
Volume / Avg.	3.67K / 428.99K
Day Range	$9.27 - $9.50
52 Wk Range	2.20 - 12.78
Market Cap	$255.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	0.11%
Days to Cover	1

Recent News

PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

3 Biopharmaceutical Stocks Bucking the Sell-Off

With tariffs sending markets reeling in the first days of the second quarter—the S&P 500 dropped roughly 10% in the five trading periods through Apr. 7, 2025—investors with cash to spend might be looking

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$9.35
Close	-
Volume / Avg.	3.67K / 428.99K
Day Range	$9.27 - $9.50
52 Wk Range	2.20 - 12.78
Market Cap	$255.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	0.11%
Days to Cover	1

About DBV Technologies

Sector

Health Care

Industry

Biotechnology

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy DBV Technologies (DBVT) stock?

You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.

View our list of the best stock brokerages

Who are DBV Technologies (DBVT) competitors?

Other companies in DBV Technologies’s space includes: Inozyme Pharma (NASDAQ:INZY), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN), Neurogene (NASDAQ:NGNE) and Tonix Pharmaceuticals (NASDAQ:TNXP).

What is the forecast, or price target, for DBV Technologies (DBVT) stock?

DBV Technologies has a consensus price target of $11.71.

What is the current price for DBV Technologies (DBVT)?

The stock price for DBV Technologies (NASDAQ: DBVT) is $9.35 last updated June 30, 2025 at 1:04 PM EDT.

Does DBV Technologies (DBVT) pay a dividend?

There are no upcoming dividends for DBV Technologies.

When is DBV Technologies (NASDAQ:DBVT) reporting earnings?

DBV Technologies’s Q2 earnings are confirmed for Tuesday, July 29, 2025.

Is DBV Technologies (DBVT) going to split?

There is no upcoming split for DBV Technologies.

What sector and industry does DBV Technologies (DBVT) operate in?

DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.